Capricorn Scientific announces an innovative collaboration with florabio AS, led by the renowned biotechnologist Dr Aziz Cayli, who brings more than 30 years of expertise in the field.
This partnership is set to redefine the benchmarks of efficiency and reliability in cell culture production, offering cutting-edge media formulations for the global biotech and pharmaceutical sectors.
This strategic alliance merges Capricorn Scientific’s deep expertise in developing animal-free formulations with florabio’s advanced focus on high-yield expression systems in media development.
Together, the companies aim to deliver solutions that drive faster, more reliable results, enabling researchers to seamlessly transition products from the lab to the clinic and to large-scale production.
“Collaborating with florabio marks a pivotal milestone in our mission to deliver high-performing, innovative solutions to the biotech industry,” said Harry Brack, Managing Director of Capricorn Scientific.
“Aziz Cayli’s unparalleled experience and passion for media optimisation perfectly align with our commitment to helping clients achieve outstanding results.”
Aziz Cayli, founder of florabio, expressed equal enthusiasm: “This partnership allows us to combine our strengths and offer groundbreaking media solutions to the global biotech and pharma markets. Together, we’re creating products that will empower researchers and producers alike.”
The first products from this exciting collaboration have already launched including a new medium for stem cells or MDCK, with more to come in 2025, catering to the demanding needs of drug discovery, regenerative medicine and other key biotechnology fields.
By uniting expertise, Capricorn Scientific and florabio are poised to accelerate innovation and reliability in cell culture media solutions.